OrbiMed Raises $3 Billion for Healthcare Investment Funds
Healthcare investment firm OrbiMed has secured $3 billion in capital commitments for two new private equity funds. The funds will focus on investments in the US, Europe, and Asia.
OrbiMed, a global investment firm focused on the healthcare sector, announced on October 15, 2026, that it has secured $3 billion in capital commitments for two new funds: OrbiMed Private Investments X and OrbiMed Asia Partners VI. The announcement was made from New York.
The OrbiMed Private Investments X fund raised over $1.9 billion to support life sciences venture capital investments in the United States and Europe. The OrbiMed Asia Partners VI fund gathered over $1 billion for healthcare growth and venture capital opportunities across Asia. Both funds aim to support and build companies in biopharmaceuticals, medical devices, diagnostics, and technology-enabled healthcare services.
OrbiMed, which manages over $21 billion in assets, cited growing opportunities in healthcare driven by advancements in artificial intelligence, diverse therapeutic approaches, and the rise of biotechnology in China. The firm's investors include medical institutions, university endowments, foundations, pension funds, and family offices.
The firm is led by 20 partners and supported by a team of over 150 professionals with expertise in corporate development, strategy, operations, and finance. OrbiMed maintains a presence in 12 global locations across key healthcare markets.